GlassScriptPhysician profile
Robert James Jordan
NPI 1336725050
$652.54
in general payments reported to CMS, 2019-2025
12 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $41.36 · 2023: $109 · 2024: $399 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $144.51 | 2023-2024 | Trelegy Ellipta |
| Novo Nordisk INC | $95.07 | 2023-2024 | Rybelsus, Ozempic |
| Amgen INC. | $90.07 | 2022-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $57.26 | 2023-2024 | Jardiance, Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $55.30 | 2024 | |
| Abbvie INC. | $47.99 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.46 | 2022-2024 | Jardiance |
| Corcept Therapeutics | $40.19 | 2024-2025 | Korlym |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.42 | 2024 | Lifevest |
| Kyowa Kirin, INC. | $21.12 | 2024 | Crysvita |
| Sanofi Pasteur INC. | $18.27 | 2024 | |
| Pfizer INC. | $14.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.